# Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)

> **NCT02622958** · PHASE3 · COMPLETED · sponsor: **Pherin Pharmaceuticals, Inc.** · enrollment: 23 (actual)

## Conditions studied

- Social Anxiety Disorder

## Interventions

- **DRUG:** PH94B
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02622958
- **Lead sponsor:** Pherin Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-10
- **Final completion:** 2015-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02622958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02622958, "Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02622958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*